Fusion Pharmaceuticals In... (FUSN)
NASDAQ: FUSN
· Real-Time Price · USD
21.55
0.03 (0.14%)
At close: Jun 03, 2024, 10:00 PM
Fusion Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -13.22 | -6.23 | -2.6 | -3.07 | -2.09 | -1.43 | -1.37 | -1.42 | -4.21 | -2.6 | -4.38 | -3.2 | -6.39 |
PEG Ratio | -5.16 | -0.11 | 0.08 | 0.20 | 0.11 | n/a | -0.05 | 0.33 | -0.28 | 0.23 | 0.15 | -0.06 | -0.2 |
PS Ratio | n/a | 20.88 | 89.50 | 9.1K | 7.24K | 1.01K | 792.10 | 189.40 | 573.39 | 302.34 | 1.05K | 659.14 | n/a |
PB Ratio | 7.36 | 3.16 | 0.95 | 1.52 | 1.01 | 0.87 | 0.72 | 0.54 | 1.56 | 0.78 | 1.38 | 1.30 | 1.61 |
P/FCF Ratio | -62.16 | -38.23 | -9.3 | -15.25 | -7.61 | -6.94 | -6.02 | -6.1 | -21.55 | -10.65 | -15.72 | -19.61 | -21.15 |
P/OCF Ratio | -65.2 | -41.48 | -9.53 | -15.8 | -7.97 | -7.28 | -6.08 | -6.23 | -22.41 | -11 | -15.84 | -19.84 | -21.75 |
OCF/S Ratio | n/a | -0.5 | -9.39 | -576 | -908.39 | -138.31 | -130.27 | -30.38 | -25.59 | -27.49 | -66.18 | -33.22 | n/a |
Debt / Equity Ratio | 0.27 | 0.23 | 0.28 | 0.25 | 0.25 | 0.25 | 0.22 | 0.08 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 |
Quick Ratio | 10.64 | 15.01 | 11.16 | 11.83 | 12.99 | 12.54 | 15.59 | 17.41 | 16.33 | 16.10 | 14.39 | 19.23 | 30.02 |
Current Ratio | 10.64 | 15.01 | 11.63 | 12.16 | 12.73 | 11.88 | 16.09 | 17.89 | 16.81 | 16.93 | 14.97 | 19.77 | 30.70 |
Asset Turnover | n/a | 0.12 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a |
Interest Coverage | -19.36 | -21.16 | -14.63 | -20.84 | -20.32 | -20.89 | -125.29 | n/a | -247.29 | -216.7 | -182.38 | -281.1 | -184.17 |
Return on Equity | -0.14 | -0.13 | -0.09 | -0.12 | -0.12 | -0.15 | -0.13 | -0.1 | -0.09 | -0.07 | -0.08 | -0.1 | -0.06 |
Return on Assets | -0.1 | -0.1 | -0.07 | -0.09 | -0.09 | -0.11 | -0.1 | -0.08 | -0.08 | -0.07 | -0.07 | -0.1 | -0.06 |
Return on Invested Capital | -0.12 | -0.11 | -0.08 | -0.1 | -0.1 | -0.12 | -0.1 | -0.09 | -0.09 | -0.07 | -0.08 | -0.1 | -0.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | 0.99 | 0.48 | -26.38 | -566.04 | -124.76 | -98.7 | -20.19 | 1.00 | 1.00 | 1.00 | 1.00 | n/a |
Net Profit Margin | n/a | -0.84 | -8.6 | -740.44 | -867.54 | -175.84 | -144.66 | -33.46 | -34.03 | -29.02 | -59.78 | -51.54 | n/a |
Pretax Profit Margin | n/a | -0.8 | -8.73 | -747.65 | -867.93 | -178.26 | -149.24 | -34.66 | -34.13 | -29.31 | -59.63 | -51.51 | n/a |
Operating Profit Margin | n/a | -0.84 | -9.67 | -785.68 | -887.68 | -174.41 | -143.4 | -33.84 | -35.09 | -29.55 | -60.05 | -52.34 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | -0.83 | -9.67 | -700.03 | -824.25 | -169.91 | -141.95 | -33.46 | -34.74 | -29.55 | -59.48 | -52.04 | n/a |